9-ING-41 CAS No.1034895-42-5

9-ING-41 (Elraglusib)/CAS No.1034895-42-5 is a maleimide-based ATP-competitive and selective glycogen synthase kinase-3β (GSK-3β) inhibitor with an IC50 of 0.71 μM. 9-ING-41 significantly leads to cell cycle arrest, autophagy and apoptosis in cancer cells. 9-ING-41 has anticancer activity and has the potential for enhancing the antitumor effects of chemotherapeutic agents.

msds of 9-ING-41 CAS No.1034895-42-5